Search filters

List of works by Ramón Cacabelos

A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease

scientific article published on 11 February 2015

ACTN3 genotype influences exercise-induced muscle damage during a marathon competition.

scientific article

An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

scientific article published in December 2008

Apolipoprotein E and central nervous system disorders: reviews of clinical findings

scientific article published on December 2010

Apolipoprotein E and neuro-psychiatric diseases

scientific article published on January 1, 2011

Can cloud-based tools accelerate Alzheimer's disease drug discovery?

scientific article

Cerebrovascular risk factors in Alzheimer's disease: Brain hemodynamics and pharmacogenomic implications

scientific article published on September 1, 2003

Conference scene: pharmacogenomics: from cell to clinic (part 2).

scientific article

Decreased levels of serum nitric oxide in different forms of dementia

scientific article published on 10 May 2007

Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics

scientific article

Dopaminergic neuroprotection with Atremorine in Parkinson´s disease

scientific article published on 9 April 2018

Editorial: Genomics and Epigenomics of Tumor and Aging Cells

scientific article published in October 2017

Epigenetic drug discovery for Alzheimer's disease

scientific article published on 03 July 2014

Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response

scientific article

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants.

scientific article published on 29 September 2010

Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration

scientific article published in October 2017

Genetic variation and pharmacogenomics in Alzheimer disease

scientific article published on January 1, 2003

Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia

scientific article

Genomics and pharmacogenomics of brain disorders

scientific article published on April 2012

Genomics and pharmacogenomics of dementia

scientific article published on 16 August 2010

Genomics and pharmacogenomics of schizophrenia

scientific article published on 16 August 2010

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics

scientific article published on 14 March 2012

Histamine and Immune Biomarkers in CNS Disorders

scientific article

Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine.

scientific article published in January 2013

In Vitro Screening for Cytotoxic Activity of Herbal Extracts

scientific article published on 13 March 2017

In vitro and in vivo cytotoxic effect of AntiGan against tumor cells

scientific article published on 27 December 2017

In vitro regulation of rat derived microglia

scientific article published on January 2003

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics

scientific article published on 06 March 2008

Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease

scientific article

Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion

scientific article published on 03 April 2013

Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices

scientific article published on 9 September 2016

Molecular genetics of Alzheimer's disease and aging

scientific article published on July 2005

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.

scientific article published on July 2007

Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection

scientific article

Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson's Disease

scientific article published on 10 February 2017

Novel Therapeutic Strategies for Dementia

scientific article published on 2 February 2016

Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease

scientific article published on February 16, 2013

Optimization of Antidepressant use with Pharmacogenetic Strategies

scientific article published in October 2017

Parkinson's Disease: From Pathogenesis to Pharmacogenomics

scientific article published on 04 March 2017

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases

scientific article published on 16 October 2018

Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics

scientific article published on September 2007

Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease

scientific article published on January 2007

Pharmacogenetic considerations in the treatment of Alzheimer's disease

scientific article published on 13 June 2016

Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease

scientific article published on 3 January 2018

Pharmacogenomics and therapeutic prospects in Alzheimer's disease

scientific article

Pharmacogenomics and therapeutic prospects in dementia

scientific article published on March 2008

Pharmacogenomics and therapeutic strategies for dementia

scientific article published on September 2009

Pharmacogenomics for the treatment of dementia

scientific article

Pharmacogenomics in Alzheimer's disease

scientific article

Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development

scientific article

Pharmacogenomics of antipsychotics efficacy for schizophrenia

scientific article published on February 1, 2011

Pharmacogenomics: from cell to clinic (Part 1).

scientific article

Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component

scientific article published in July 2004

Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia

scientific article published in October 2017

Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study

scientific article published in September 2003

Prevention of Chronic Experimental Colitis Induced by Dextran Sulphate Sodium (DSS) in Mice Treated with FR91

scientific article published on February 12, 2012

Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin

scientific article published on 17 June 2009

Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury

scientific article published on 14 February 2008

Resting-state network disruption and APOE genotype in Alzheimer's disease: a lagged functional connectivity study

scientific article

Role of bioactive lipofishins in prevention of inflammation and colon cancer

scientific article published on 24 November 2017

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease

scientific article published on 29 March 2006

Sirtuins in Alzheimer's Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics

article

The application of functional genomics to Alzheimer's disease

scientific article

Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice

scientific article published on September 16, 2012

Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine

scientific article